Tag Archives: HEA

PR Newswire

Ecolog International Appoints Juan Chaparro as Executive Director and Chairman of the Board

Leave a comment

DUBAI, UAE, Jan. 9, 2023 /PRNewswire/ — Ecolog International, a leading global provider of integrated services and logistics solutions for life support, supply chain, energy and healthcare industries, announced the appointment of Juan Chaparro as Executive Chairman of the Board, as of 01 January 2023.

With over 30 years’ experience as an executive in supply chain management, procurement and sourcing, having worked for globally recognized companies such as Zara (Inditex), Esprit and Primark, Mr. Chaparro brings a wealth of expertise in complex logistics management in fast-paced environments as well as the B2C focus. This aligns with Ecolog’s vision and growth strategy and makes him a valuable addition to the leadership team.

Commenting on his new role, Juan Chaparro said, “Ecolog is a unique organization with distinguished history and the potential to help improve all aspects of the lives of the people it serves, from water and sanitation to catering, healthcare and the wider environment. Its people-driven focus and family-like culture, both internally and externally, are among the many reasons I am excited to be joining”

Mr. Chaparro’s appointment comes at a pivotal time as Ecolog progresses with expanding its service offering into customized healthcare solutions, clean water and renewable energy as well as sustainable food technologies. With projects in both emerging and established markets catering to various institutional clients, Ecolog is set to leverage its scale and footprint to also provide direct services to consumers.

“This is an exciting phase of the company’s development, investigating how we can mobilize our most valuable asset – our people and their skills – to grow their abilities and expand our capacity to assist more people in more ways. I am eager to contribute in my new role and honoured to lead our incredible team towards new heights of success”, said Juan Chaparro.

About Ecolog

Ecolog International is a global provider of integrated services and sustainable solutions tailored to the needs of diverse range of customers in the humanitarian, healthcare, energy, mining and infrastructure industries. Incorporated over two decades ago in Germany, with the footprint in nearly 40 countries, the company’s service portfolio includes life support, supply chain management, construction, engineering, healthcare and environmental services. Driven by the passion to serve people and communities, Ecolog has an extensive experience in providing fast response solutions, integrated and complex logistics as well as mission-critical operations.

Press Contact: press@ecolog-international.com T: +971 (0)4 299 4500 

PR Newswire

Waterdrop and Jemincare Collaborate on the “Digital Service Platform for CKD Patients”

Leave a comment

BEIJING, Jan. 4, 2023 /PRNewswire/ — Waterdrop and Jemincare recently reached a cooperation, according to which both sides will jointly launch the “Digital Service Platform for CKD Patients”. Featuring both online and offline service modules ranging from follow-up visits and consultation with doctors to interpretation of data reports and popularization of disease knowledge, the platform is expected to offer patients efficient, convenient, and integrated chronic disease management services, and enhance their experience even without visiting hospitals.

Jemincare is committed to delivering CKD patients with a better experience in drug use, diagnosis, and treatment by offering services outside hospitals throughout the course of the disease. Boasting a series of proven tools devised to improve patient management services, Waterdrop Patient Platform, built on a patient-centric approach, can provide patients with services in the whole disease course outside hospitals. The bilateral cooperation is of positive significance in helping CKD patients solve problems associated with diagnosis, drug use, and daily care during the long cycle of treatment.

According to Yao Hu, co-founder of Waterdrop and General Manager of Waterdrop’s Pharmaceutical Innovation Business Unit, Waterdrop Patient Platform enjoys a solid foundation in offering patient services across the whole disease course outside hospitals and has put in place a multi-dimensional operation system that provides patients with one-on-one Q&A services related to reporting interpretation, drug use, disease knowledge explanation, nutrition & lifestyle guidance, and psychological support. As of September 2022, the platform had served 3 million patients with severe diseases and set up nearly 1,600 communities that covered patients of 12 common serious diseases and rare diseases. “Centering on patient needs, Waterdrop Patient Platform will further optimize service processes to bring more comprehensive, professional, and considerate services to patients. Also, empowered by digital technologies, the platform can help pharmaceutical partners boost quality and efficiency.”

About Waterdrop Inc.

Waterdrop Inc. (NYSE: WDH) is a leading technology platform dedicated to insurance and healthcare service with a positive social impact. Founded in 2016, with the comprehensive coverage of Waterdrop Insurance Marketplace and Waterdrop Medical Crowdfunding, Waterdrop aims to bring insurance and healthcare service to billions through technology. For more information, please visit www.waterdrop-inc.com.

Safe Harbor Statement

This press release contains statements that may constitute “forward-looking” statements pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “likely to,” and similar statements. Statements that are not historical facts, including statements about Waterdrop’s beliefs, plans, and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. Further information regarding these and other risks is included in Waterdrop’s filings with the SEC. All information provided in this press release is as of the date of this press release, and Waterdrop does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

Cision View original content:https://www.prnewswire.com/news-releases/waterdrop-and-jemincare-collaborate-on-the-digital-service-platform-for-ckd-patients-301713005.html

Source: Waterdrop Inc.

PR Newswire

Complete Genomics to Present its Multiple, Innovative Sequencing Platforms at BIOTECH SHOWCASE™ 2023

Leave a comment

Enhanced sequencing capabilities offer opportunity to accelerate breakthroughs in life science research

SAN JOSE, Calif., Dec. 30, 2022 /PRNewswire/ — Complete Genomics Inc（https://completegenomics.mgiamericas.com/）, a subsidiary of MGI Tech Co., Ltd., today announced that it is presenting at Biotech Showcase™ 2023, taking place in San Francisco at the same time as the JP Morgan healthcare conference. Registered attendees can view Complete Genomics presentation live and through 24×7 on-demand access if scheduling does not allow viewing during the main event week.

Complete Genomics offers complete high throughput sequencing instrumentation and related products, including sample extraction, library prep, automation system, sequencing platforms, and bioinformatics. Rade Drmanac, PhD, Chief Scientific Officer, will provide an overview of the complete suite of high throughput sequencing instruments and related products. The live presentation will be on:

Date: Monday, January 9
Time: 16:30pm PST
Venue: Hilton San Francisco Union Square Hotel
Room: Franciscan D

“Dating back to as early as 2006, we have been at the forefront of life science innovation and continue to redefine sequencing possibilities through our innovative DNBSEQTM technology,” said Dr. Drmanac. “Over the years, our massively parallel sequencing (MPS) and sample processing automation products have empowered countless customers and partners around the world in their scientific research and clinical applications. As we aim to broaden our reach into the US market, we look forward to attending Biotech Showcase™ to demonstrate our enhanced sequencing capabilities and how we can help our partners accelerate breakthroughs in life science and healthcare with this state-of-the-art technology.”

Complete Genomics sequencing platforms are based on DNBSEQTM, sample extraction, library prep, automation system, and bioinformatics to the US market and beyond. In August 2022, its DNBSEQ-G400C* sequencer was released in the US with immediate adoption in several customer labs and partnerships with various life science companies.

Moreover, Complete Genomics will launch at Biotech Showcase the “Empowerment Program America”, which will bring choice to sequencing by collaborating with researchers to develop grant proposals.

Biotech Showcase, produced by Demy-Colton and EBD Group, is an investor conference focused on driving advances in therapeutic development by providing a sophisticated networking platform for executives and investors that fosters investment and partnership opportunities. The conference takes place each year during the course of one of the industry’s largest gatherings and busiest weeks.

“We are delighted that Complete Genomics will be joining us in San Francisco and presenting at Biotech Showcase this year,” said Sara Demy, CEO of Demy-Colton. “Biotech Showcase is a prime occasion for life science entrepreneurs and investors to come together to discover the potential of innovative technologies that will drive the future of drug discovery.”

ABOUT BIOTECH SHOWCASE

Biotech Showcase is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place. Investors and biopharmaceutical executives from around the world gather at Biotech Showcase during this bellwether week which sets the tone for the coming year. Now in its 15th year, this well-established, highly respected conference features multiple tracks of presenting companies, plenary sessions, workshops, networking, and an opportunity to schedule one-to-one meetings. Biotech Showcase is produced by Demy-Colton and EBD Group. Both organizations have a long history of producing high-quality programs that support the biotechnology and broader life sciences industry.

ABOUT COMPLETE GENOMICS

Complete Genomics, a subsidiary of MGI Tech Co., Ltd., is a global life science company offering lab automation and a comprehensive high throughput sequencing product portfolio. Founded in 2006 and currently located in San Jose, California, Complete Genomics maintains a demo lab and full supply center with all of its sequencers and lab automation equipment on display. Complete Genomics released its first next-generation sequencing system, the DNBSEQ-G400C* platform in the US, in August 2022. For all sequencer specifications, please visit the Complete Genomics website.

Follow Complete Genomics on Twitter at @ Complete Genomics and Biotech Showcase at @EBDGroup and @Demy_Colton and tag your posts with #BiotechShowcase

*Unless otherwise informed, StandardMPS and CoolMPS sequencing reagents, and sequencers for use with such reagents are not available in Germany, Spain, UK, Sweden, Belgium, Italy, Finland, Czech Republic, Switzerland, Portugal, Austria, and Romania. Unless otherwise informed, StandardMPS sequencing reagents, and sequencers for use with such reagents are not available in Hong Kong. No purchase orders for StandardMPS products will be accepted in the USA until after January 1, 2023.

Cision View original content:https://www.prnewswire.com/news-releases/complete-genomics-to-present-its-multiple-innovative-sequencing-platforms-at-biotech-showcase-2023-301711121.html

PR Newswire

CGTN: Vitality under COVID-19: China’s smart ports aid increased throughput

Leave a comment

BEIJING, Dec. 29, 2022 /PRNewswire/ — China’s Qingdao Port, a subsidiary of Shandong Port Group and the second-largest foreign trade port in east China’s Shandong Province, has seen an increase in anchorage rotations of very large container ships, according to China Media Group.

The port has handled ultra-large container ships more than 300 times. Ultra-large container ships are usually 400 meters long and have a capacity of over 20,000 twenty-foot equivalent units (TEU).

The port has also handled 200-meter-long container ships more than 3,900 times, a 7-percent increase year on year, CMG said.

Handling that much freight under the impact of COVID-19 is challenging, particularly with reduced labor. However, the unloading rate at the Qingdao Port increased by 16 percent from January to November, thanks to the port’s record-setting intelligent system.

The COVID-19 pandemic has greatly impacted the global port and water transportation industry. However, China’s major ports have seen an increase in throughput and made significant progress in digital and intelligent construction, thereby playing a leading role in the intelligent development of ports globally.

Qingdao Port is the world’s first to have an air-track intelligent transporting system capable of handling 1.5 million TEUs annually. The system set a new world record in June for managing as many as 67.76 TEUs in an hour, with an average of 60.18 TEUs per hour, a 14.2-percent jump from its previous record.

China now leads the world in the number of automated terminals, both built and under construction, according to the Ministry of Transport. All the major ports in Shanghai and Tianjin are equipped with automated bridge cranes or tracks.

Coupled with the continuous investment in domestic ports and a large number of high-tech enterprises, the concept and practice of smart port construction have been innovative, Mi Weijian, a professor at Shanghai Maritime University, told Xinhua.

For large corporate ports, such as the Shandong Port Science and Technology Group, in-house cooperation is the key to upgrading existing facilities into a fully automated waterfront container terminal, which helps reduce the overall costs by 70 percent compared with newly built terminals, according to Xinhua.

“Now we have traditional terminals, semi-automatic terminals and fully automatic terminals,” said Wang Yusheng, deputy general manager of the group. “The loading and unloading of a ship can be done in three different kinds of terminals, which maximizes the integration of terminal resources.

Link: https://news.cgtn.com/news/2022-12-28/Vitality-under-COVID-19-China-s-smart-ports-aid-increased-throughput-1g7OLnTDJtK/index.html

PR Newswire

CGTN: Vitality under COVID-19: China gears up for medical supplies

Leave a comment

BEIJING, Dec. 28, 2022 /PRNewswire/ — China has made efforts to ensure the medical supplies needed for COVID-19 prevention and control after it loosened its epidemic measures in early December, which was followed by an increase in infections and surging demand for medicines.

The country’s National Medical Products Administration has urged medical regulatory authorities at all levels to adopt various enhanced measures, such as sending personnel to factories for inspections and strengthening quality sampling inspections, to safeguard medical supplies needed, such as therapeutic medicines, testing reagents, vaccines, medical masks and protective suits.

Pharmaceutical enterprises have also striven to secure supply.

East China’s Shandong Province is the largest production base of raw materials for antipyretic analgesic medicines in the country. Many companies in the province focus on export markets, but quickly adjusted their distribution channels and increased production capacity in order to secure domestic supplies.

Local government departments have also helped companies to access to raw materials and transportation to ensure the stability of the industrial supply chain for key products. Raw materials and preparations have been produced at full capacity, Zhang Haibo, director at the Department of Industry and Information Technology in Shandong Province, told China Media Group.

Zhang said that they would also coordinate between production enterprises, medical institutions and commercial circulation among others, and organize the delivery of medicines to improve the accessibility to medicines for the people.

Pharmaceutical companies across the country have also adopted measures, such as technological transformations and new production lines, to expand production capacity and meet market demand.

Tan Guanghua, general manager at Pharmaceutical Business Department of Guangzhou Xiangxue Pharmaceutical Co., LTD. in south China’s Guangdong Province, said that they have opened two new production lines to produce Chinese patent medicines and increase daily production capacity by about 50 percent.

For antigen detection reagents, Zhou Jian, deputy general of the consumer product industry department at the Ministry of Industry and Information Technology, said at a press conference on December 14 that all 42 manufacturers have been included in a government white list and were required to procure and store key materials to ensure sufficient supply of the reagents.

Zhou said the country’s vaccine could also meet the needs of the current epidemic prevention and control, since China has built the world’s largest production line of COVID-19 vaccine, with an annual capacity of more than 7 billion doses and an output of over 5.5 billion doses. 

In response to the rising demand for N95 masks, the country has improved its production, according to Zhou.

Medical services provided by hospitals and clinics

Multiple makeshift fever clinics have been set up at the grassroots level in cities in east China’s Jiangsu and Zhejiang provinces, central Henan Province and southern Guangdong Province to provide timely treatment for people with COVID-19 symptoms.

Doctors in the makeshift clinics would diagnose patients and prescribe drugs, making it convenient for locals in urgent need of medical services.

In southwest China’s Guizhou Province, some community clinics have opened online consulting services which support medicine prescription and delivery. Some medical institutions have set up special treatment channels for vulnerable groups of people such as the elderly, the pregnant and infants.

Shanghai has expanded the capacity of fever clinics in community health service centers, branch centers and village clinics to receive the increasing numbers of patients.

China has a three-tier system to grade hospitals, with primary, secondary and tertiary hospitals. Primary and secondary hospitals usually receive patients from certain communities and districts. In Shanghai, these two levels of hospitals so far have responded to 60 percent of the whole treatment requirements.

Tertiary hospitals have the largest number of beds and provide comprehensive medical services and are at the top of the list. Many tertiary hospitals in Shanghai have enlarged their ICU capacity and increased their medicine inventories.

Beijing Municipality urged its tertiary hospitals to play a role in medical treatment, give full play to expert teams, and provide specific treatment for critically ill patients who are affected by the novel coronavirus in accordance with their cases, and make every effort to raise the cure rate and reduce the mortality rate, according to a spokesperson at a press conference held in Beijing on Saturday.

https://news.cgtn.com/news/2022-12-25/Vitality-under-COVID-19-China-gears-up-for-medical-supplies-1g2XIXZjmGA/index.html

PR Newswire

CGTN: Infrastructure, vaccines and space: China-Arab sci-tech cooperation

Leave a comment

BEIJING, Dec. 12, 2022 /PRNewswire/ — Under the Belt and Road Initiative (BRI), China-Arab cooperation in the fields of infrastructure, space and health has been continuously developed in a sustainable manner.

China has vowed to accelerate the development of the China-Arab inter-governmental science and technology innovation cooperation mechanism.

The country will implement more partner projects, and continue to improve the sci-tech capabilities of Arab states.

Lusail Stadium: first China-built World Cup venue

Lusail Stadium, the main venue for this year’s World Cup, was constructed with China Railway Construction Corporation as the main contractor.

Shaped like a date palm bowl or an enamel lantern, the stadium will host the World Cup final, scheduled for December 18.

It is the first time a Chinese company has built a World Cup venue, which is featured on the new 10-riyal banknote of Qatar.

“The Lusail Stadium is by far the world’s largest, most advanced and most complex professional football stadium built to FIFA standards,” Li Chongyang, head of the Chinese side of the engineering team, told the China Media Group (CMG).

Lusail Stadium, which can host 80,000 spectators, shows Chinese enterprises’ technical capabilities and service levels, Hassan Al Thawadi, secretary general of the Supreme Committee for Delivery and Legacy for 2022 FIFA World Cup, told CGTN.

China-UAE joint vaccines projects

The United Arab Emirates (UAE) helped China with the clinical trial of its COVID-19 vaccine and later established localized production lines.

In 2020, the UAE approved registration of an inactivated vaccine developed by China’s Sinopharm.

“The UAE was the first country to approach a Chinese vaccine,” Ali Obaid Al Dhaheri, the UAE ambassador to China, told CGTN. “The production facility can produce 200 million doses per year. The vaccine is not for the UAE, not for China, but for the rest of the world.”

Space cooperation

China is pushing forward space cooperation with countries participating in the BRI.

China and Saudi Arabia signed a memorandum of understanding on March 16, 2017, sharing the scientific data in space cooperation.

The two then jointly unveiled three lunar images acquired through cooperation on the relay satellite mission for Chang’e-4 lunar probe, according to the China National Space Administration.

In 2018, the China-Arab States BDS/GNSS Center, the first overseas center for China’s indigenous Beidou Navigation Satellite System (BDS), was inaugurated in Tunisia. BDS-related cooperation expanded to more Arab states in 2021 as they agreed to implement more pilot projects.

In addition, Kuwait’s national satellite team looks forward to cooperating with China.

Link: https://news.cgtn.com/news/2022-12-10/Infrastructure-vaccines-and-space-China-Arab-sci-tech-cooperation-1fDKJNs4QuI/index.html

PR Newswire

Waterdrop Inc. to Report Third Quarter 2022 Financial Results on December 6, 2022

Leave a comment

BEIJING, Dec. 2, 2022 /PRNewswire/ — Waterdrop Inc. (NYSE: WDH) (“Waterdrop” or the “Company”), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2022, before U.S. markets open on Tuesday, December 6, 2022.

Waterdrop’s management team will hold a conference call on December 6, 2022 at 7:00 AM U.S. Eastern Time (8:00 PM Beijing/Hong Kong Time on the same day) to discuss the financial results. Dial-in details for the earnings conference call are as follows:

International:

1-412-317-6061

United States Toll Free:

1-888-317-6003

Hong Kong Toll Free:

800-963976

Hong Kong:

852-58081995

Mainland China:

4001-206115

Elite Entry Number:

5857670

Please dial in 15 minutes before the call is scheduled to begin and provide the Elite Entry Number to join the call.

A telephone replay will be accessible two hours after the conclusion of the conference call through December 13, 2022 by dialing the following numbers:

United States Toll Free:

1-877-344-7529

International:

1-412-317-0088

Access Code:

4470089

Additionally, a live and archived webcast of the conference call will be available at the Company’s investor relations website at http://ir.waterdrop-inc.com/.

About Waterdrop Inc.

Waterdrop Inc. (NYSE: WDH) is a leading technology platform dedicated to insurance and healthcare service with a positive social impact. Founded in 2016, with the comprehensive coverage of Waterdrop Insurance Marketplace and Waterdrop Medical Crowdfunding, Waterdrop aims to bring insurance and healthcare service to billions through technology. For more information, please visit www.waterdrop-inc.com.

For investor inquiries, please contact

Waterdrop Inc.
IR@shuidi-inc.com

Cision View original content:https://www.prnewswire.com/news-releases/waterdrop-inc-to-report-third-quarter-2022-financial-results-on-december-6-2022-301692247.html

Source: Waterdrop Inc.

PR Newswire

Fovia Ai to Showcase AI Visualization Integrations at IAIP Exhibit, RSNA 2022

Leave a comment

Fovia Ai Provides Efficiency Gains for Radiology Workflows

CHICAGO, Nov. 27, 2022 /PRNewswire/ — Fovia Ai, Inc., a subsidiary of Fovia, Inc., a world leader in advanced visualization for nearly two decades and a preeminent provider of zero-footprint, cloud-based imaging SDKs, today announced that it will be showcasing AI visualization, navigation and seamless integrations of AI that provide significant efficiency gains in the radiology ecosystem, in the Imaging Artificial Intelligence in Practice (IAIP) demonstration being held November 27 – November 30 at the 108th Scientific Assembly and Annual Meeting of the Radiology Society of North America (RSNA 2022) at McCormick Place in Chicago.

Fovia Ai utilizes XStream® aiCockpit® in collaborative exhibit showcasing AI integrations in the radiology ecosystem
Fovia Ai utilizes XStream® aiCockpit® in collaborative exhibit showcasing AI integrations in the radiology ecosystem

RSNA attendees visiting the IAIP exhibit will be able to explore AI integrations from 19 exhibitors, with 30 products, based on real-world clinical scenarios and will see live demonstrations of Fovia Ai software integrated with vendors including 3M M*Modal, Bayer, GE Healthcare, Hyperfine, Lunit, Microsoft, Nuance, Nvidia, Siemens Healthineers, Smart Reporting, Qvera, Qure.ai, Therapixel and Visage Imaging. The interactive exhibit provides attendees access to emerging AI technologies, demonstrates the interoperability standards needed to integrate into the workflow of diagnostic radiology, and highlights AI-driven products that remove barriers to clinical adoption.

“Fovia is proud to join the IAIP emphasizing interoperability. It has been enlightening to work with the other vendors to connect many disparate AI products in real-world, clinical scenarios while providing unprecedented efficiency gains with XStream® aiCockpit®. We are pleased that the existence of standards such as FHIR, FHIRcast, DICOMweb/WADO, HL7, RSNA/ACR CDE’s (including RadElements and RadLex), and SOLE allow our AI viewer technology to easily communicate and interact with the various AI vendors’ algos, AI Orchestrator Systems, Reporting Systems and PACS Archives/Viewers. This demo will show the future of interconnected AI workflows within the radiology ecosystem,” stated Fovia Ai’s Chief Technology Officer, Kevin Kreeger, Ph.D.

Adjacent to the IAIP demonstration, in the Fovia Ai booth (#4129), attendees can:

  • Explore AI-driven advanced visualization via XStream® aiCockpit® and XStream® aiPlatform®, and see how Fovia Ai technology enables radiologists and clinicians to efficiently access, interact with and modify AI results directly within their existing workflows. Preview select workflows integrated with a variety of vendors.
  • Discover how XStream® aiCockpit® provides multiple paths for integrating AI. Learn how to leverage AI capabilities for PACS, reporting systems, universal viewers and hospital systems in a variety of ways—embedded zero-footprint web app, white-label floating web browser, or comprehensive SDK Integration. Learn more.
  • Learn how to quickly develop advanced visualization applications that achieve efficiency gains by leveraging optimized segmentation tools, automated image processing and efficient reporting of clinical results. Schedule a meeting at RSNA.

To learn more about Fovia and Fovia Ai’s complete product suites or arrange a demonstration at the 108th Scientific Assembly and Annual Meeting of the Radiological Society of North America, November 27 – November 30, contact us.

About Fovia Ai 

Fovia Ai, Inc. is a subsidiary of Fovia, Inc., a world leader in advanced visualization, a preeminent provider of cloud-based, zero-footprint imaging SDKs, and the developer of High Definition Volume Rendering®, XStream® HDVR®, F.A.S.T.® RapidPrint® and TruRender®. Fovia Ai’s flagship products, XStream® aiCockpit® and XStream® aiPlatform® enable radiologists and clinicians to efficiently access AI results directly within their existing workflows from any PACS, worklist, dictation software or hospital system. Complementary products in Fovia Ai’s product suite include F.A.S.T.® AI Annotation, F.A.S.T.® AI Validation, F.A.S.T.® AI Workflows, F.A.S.T.® Interactive AI and F.A.S.T.® Interactive Segmentation, collectively providing tools to annotate, validate, modify, accept/reject, interact with and segment data. The flexible architecture of Fovia Ai’s product suite and Fovia’s nearly two decades of radiology integration experience facilitate seamless integrations with a variety of partners, platforms, processors and operating systems.

For additional information and to learn more about commercial, academic or research licensing, visit fovia.ai or fovia.com.

IMPORTANT REGULATORY NOTICE: The applications mentioned herein are for investigational use only at this time.

Source: Fovia Ai, Inc.

PR Newswire

VUNO Showcases their AI Solutions and Research Results at RSNA 2022

Leave a comment

SEOUL, South Korea, Nov. 25, 2022 /PRNewswire/ — VUNO Inc., a leading South Korean artificial intelligence (AI) developer, announced that it will participate in the Radiological Society of North America 2022 (RSNA 2022). This year, VUNO will focus on highlighting how their breakthrough AI technology drives real world clinical value across radiological workflows and how their solutions contribute to improving quality of patient care. The exhibition will be held at McCormick Place in Chicago, Illinois from Nov. 27-Dec.1, 2022.

Meet VUNO at RSNA 2022
Meet VUNO at RSNA 2022

VUNO will showcase four medical artificial intelligence solutions: VUNO Med®-DeepBrain®, VUNO Med®–LungCT AITM, VUNO Med®-Chest X-rayTM and VUNO Med®-BoneAgeTM, which can all be seamlessly integrated with PACS (Picture Archiving and Communication System), EMR (Electronic Medical Record) systems, and medical device hardware. A simulation reading room will be set up at VUNO’s booth, so visitors can experience how VUNO Med® solutions integrate with PACS. Visitors will also have the chance to demo the four medical artificial intelligence solutions as standalone products.

VUNO will present two research achievements about VUNO Med®-DeepBrain®, a medical AI solution that performs brain volumetric and quantitative analysis of cerebral MR images, at a neuroradiology poster session. They delve into how AI algorithms can be used to identify neuroimaging biomarkers and support decision making process in practice. VUNO will discuss an automatic medial temporal lobe atrophy (MTA) score (also known as Scheltens’ scale) prediction algorithm and a white matter hyperintensity (WMH) quantification model accompanying the Fazekas scale estimation.

Yeha Lee, CEO of VUNO said, “Through participating in RSNA 2022, VUNO will introduce various clinical research achievements to the global radiology community and demonstrate the capabilities and impact of our AI technology,” adding “we plan to expand our partnerships with overseas partner companies and medical institutions by offering the opportunity for attendees to directly experience VUNO Med® solutions.”

About VUNO Inc.

VUNO is a leading AI medical software company that develops deep learning-based AI medical solutions in the fields of medical imaging, bio-signal and digital pathology. We strive to optimize and improve clinical workflows, while empowering medical practitioners to make better diagnostic decisions faster and more accurately – providing quality patient care and treatment planning. For more information, visit www.vuno.co.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/vuno-showcases-their-ai-solutions-and-research-results-at-rsna-2022-301687126.html

Source: VUNO Inc.

PR Newswire

Everise Guatemala Celebrates 10 Years of Delivering Excellent Customer Experience

Leave a comment

Today, its 3,800-strong champion workforce and operations power 450,000 daily customer interactions for leading healthcare, travel and logistics companies

GUATEMALA CITY, Nov. 19, 2022 /PRNewswire/ — Everise Guatemala celebrated their 10th year anniversary today, marking a decade since its contact center was established in 2012. Today, the company has created over 3,800 jobs in the Guatemalan community and conducts over 450,000 customer interactions on a daily basis for leading businesses.

Everise, one of the fastest growing healthcare services outsourcing companies in the world, was founded in 2016. Since then, the business accelerated its growth and transformation, evolving from a mid-sized BPO operation into a leading healthcare services company with a global footprint.

Over the years, the business has established a strong presence rooted in making a positive impact on the Guatemalan community. Everise Guatemala provides omnichannel and wide-ranging customer experience support with end-to-end healthcare capabilities and counts some of the world’s leading healthcare and logistics brands amongst its clientele. The company has been able to grow its customer champion talent team over 10x since inception, by maintaining a consistently strong reputation as an employer of choice and robust talent management, referral and rewards programs.

Everise Guatemala was recognized for its strong COVID-19 response, and for being one of the fastest outsourcing businesses to prioritize employee safety and wellbeing by pivoting to a work-from-home arrangement. As early as 22nd March, the company was able to seamlessly transition its employees to work from home with minimal service disruption and the highest standards of security. Everise retained its employees with no layoffs throughout the pandemic, instead growing the company exponentially by winning new business and expanding its team.

The company celebrated with a 10th anniversary event held at its Avenida Hincapie site, officiated by government officials, Guillermo Montano, president of Agexport, as well as Jeremy Jepperson, Chief Operating Officer of Everise, and Sheena Ponnappan, Chief People Officer of Everise. The celebrations included an opening ceremony and press conference.

“Everise is proud to commemorate our stellar growth over 10 years in Guatemala. With the support of our trusted clients and partners and the local government, we have been able to grow the company from strength to strength and generate a positive impact on the community through job creation and community empowerment. We look forward to many more years of delivering transformational customer experience to the world’s leading brands,” shared Sudhir Agarwal, Founder & Chief Executive Officer of Everise.

“Everise’s evolution into a leading healthcare services company has only been possible with taking a people-focused approach towards growth. By keeping people at the heart of everything we do, we have been able to scale while attracting and retaining some of the best talent to join us in one of the best cultures and workplaces to work in,” shared Sheena Ponnappan, Chief People Officer of Everise.

Today, Everise enjoys the highest Glassdoor and Indeed ratings in the outsourcing industry in Guatemala – 4.8 out of 5 stars on Glassdoor, and 4.4 stars on Indeed. Everise has also won multiple awards for its industry-leading culture, including being named one of Newsweek’s 100 Most Loved Workplaces in America for two consecutive years in 2021 and 2022, and bagging the Gold Stevie Award for Employer of the Year — Consumer Services in 2022.

Everise Guatemala Timeline & Key Milestones

  • 2012: Established as part of prior business operations with a pilot group of 25 people.
  • 2014-2015: Expanded operations and moved to a new facility. Grew to a workforce of 350 people by the end of 2015.
  • January 2017: Officially incorporated as Everise Guatemala.
  • June 2019: Official opening of brand new state-of-the-art 79,115 square foot office in Avenida Hincapie hosting over 1,500 production stations. The facility boasts a 26,812 square foot rooftop recreational centre with soccer and basketball courts, running trail and magnificent views of the city.
  • 2020: In the face of the COVID-19 pandemic onslaught, Everise Guatemala was among the fastest companies to pivot to a work-from-home workforce, prioritizing employees’ wellbeing and safety. The company implemented its work-from-home policy with effect from 22nd March, equipping champions with the IT infrastructure necessary to work remotely with minimal operational disruption and the highest standards of IT security.
  • 2021-2022: Drove exponential growth in client portfolio, developing end-to-end healthcare capabilities that enabled Everise to on board some of the world’s leading healthcare brands.
  • September 2022: Everise unveiled a new nearshore site in neighboring Colombia, with the official opening of its new Bogota office.
  • November 2022: Celebrated 10th year anniversary with its largest workforce to date, with plans for continued growth and expansion.

About Everise

Everise is a technology-enabled outsourcing firm with expertise in transforming healthcare and technology customer experiences globally. The Company’s unique approach combines customer and technical support services with AI, robotic process automation, analytics, and secure cloud-based technology. Some of the world’s most loved brands have products and services that are perfected, protected, supported, and sold by Everise.

Our innovative digital outsourcing services are high performing, scalable, secure, agile, and have fluent proficiency in 32 languages, which helps brands to create seamless customer, product, digital, and home experiences. We strategically operate in seven markets to enable our partners to economically reach their customers across the globe. Learn more at www.weareeverise.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/everise-guatemala-celebrates-10-years-of-delivering-excellent-customer-experience-301682547.html